| Insider | Feld Michael |
|---|---|
| Title | EVP, CRO & Pres. Life Sciences |
| Transaction Date | Jan 26, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 26, 2026 |
| Shares Sold | 75 |
| Price per Share | $202.73 |
| Total Value | $15,204.75 |
| Shares Owned After | 16,431 |
| Derivative | No |
| Accession Number | 0001628280-26-003734 |
| Document | View SEC Filing |